European Equity pre-Market Summary - 29th September 2026: European bourses set for a slightly firmer open; Hapag lifts outlook, with Lindt issues a profit warning

A pre-market wrap of this kind is a liquidity and positioning note rather than a signal event; its value lies in which items carry follow-through into the cash session and which fade at the open.

Newsquawk StaffPublished On the live feed at , 20 minutes before this page
Newsquawk headlinesUTC

European Equity pre-Market Summary - 29th September 2026: European bourses set for a slightly firmer open; Hapag lifts outlook, with Lindt issues a profit warning

Houthis reportedly attacked oil facilities in Yanbu on the Red Sea with a large number of ballistic missiles and drones; satellites showed several giant oil storage tanks at the Al-Mu'ajiz terminal in southern Saudi Arabia ablaze, Al Akhbar reports

RBA Governor Bullock says inflationary pressures to last longer than expected; inflation is driven by domestic capacity pressures; Board will raise rates again if needed

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Stories:

  • AstraZeneca (AZN LN): Co. is to invest USD 2bln in Summit Therapeutics (SMMT) and collaborate on cancer drugs, according to WSJ.
  • Airbus (AIR FP): Co. faces slower-than-expected deliveries in September after recently discovered A321neo fuselage glitch, Reuters reports citing sources.
  • Rexel (RXL FP): Co. launches a c. EUR 500mln capital increase, without shareholders’ preferential subscription right, to partially fund the acquisition of GCG.

Trading Updates:

  • Hapag Lloyd (HLA GY): Co. raises outlook for FY26, citing strong market demand and the ongoing positive development of spot freight rates.
  • Lindt & Spruengli (LISN SW), -5.7%: H1 2026 (CHF): Sales 2.33bln (exp. 2.36bln). Cuts FY26 Organic Sales Growth to 0-2% (prev. guided 4-6%).

Broker Moves:

  • Rentokil (RTO LN), -1.6%: downgraded to Equal Weight from Overweight at Morgan Stanley
  • Fresenius Medical Care (FME GY): assumed with Hold at Berenberg
  • Eurofins Scientific (ERF FP), -1.5%: downgraded to Market Perform from Outperform at Bernstein

The numbers after the Co. & ticker are the pre-market indication via Tradegate

Context

The pattern that has recurred in comparable sessions is that idiosyncratic corporate news drives single-stock dispersion while the index-level indication, here only slightly firmer, tends to be hostage to the US session and any macro prints later in the day. The Lindt cut is the cleanest read-through: a guidance reset of that magnitude in a defensive staple has historically prompted peer scrutiny across European consumer names on pricing power and volume elasticity, and the size of the pre-market markdown relative to the downgrade-driven moves in Rentokil and Eurofins reflects the difference between new fundamental information and a rerating of existing views. Hapag's upgrade, tied to spot freight rates, is the cyclical counterpoint and typically pulls the container peer set with it, since freight-rate momentum is a shared input rather than company-specific. The Airbus delivery slippage and the Rexel discounted raise are supply-chain and dilution stories respectively, the former watched for read-across to the aerospace supplier chain, the latter for the discount and take-up as the tell on appetite for acquisition-funding paper. Follow-ons are the cash-open confirmation of the Tradegate indications, any broker response to the Lindt reset, and whether the AstraZeneca-Summit collaboration is corroborated beyond the initial report.

Related headlines

The whole workspace, free to try.

Try it free